Black Rock Inc. Enanta Pharmaceuticals Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 1,847,519 shares of ENTA stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,847,519
Previous 1,839,055
0.46%
Holding current value
$11.3 Million
Previous $32.1 Million
25.37%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ENTA
# of Institutions
110Shares Held
21.1MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$12.9 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$12.1 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$9.14 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.1MShares$6.73 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1MShares$6.1 Million0.17% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $126M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...